AstraZeneca

Mentioned in 10 analyzed podcast episodes across 8 shows

Mentioned On

Pharma and BioTech Daily The BioHub - by Avetix The Biotech Startups Podcast PBD Podcast Latent Space: The AI Engineer Podcast Animal Spirits Podcast Congressional Dish Leaked

Episode Mentions

Pharma and BioTech Daily · May 13, 2026

Pfizer's $85M Breast Cancer Deal & FDA Shakeup | Pharma and Biotech Daily

“Faced immunogenicity challenges in endocrine disorder treatment, underperforming against Ascendis Pharma's Yorvipath”

FDA Leadership Transition and Regulatory StrategyPrecision Oncology and Targeted Breast Cancer TherapiesBiosimilar Competition and Market Erosion

View Analysis

The BioHub - by Avetix · May 12, 2026

Episode 172 - Jonathan Sadeh - EVP, Head of R&D and CMO of Bausch Health

“Mid-career employer where Dr. Sadeh led global programs in respiratory, immunology, cardiovascular, and neuroscience”

Career progression in large pharmaceutical organizationsCross-functional collaboration in drug developmentTherapeutic area diversification strategy

View Analysis

The Biotech Startups Podcast · May 7, 2026

🧬 Engineering a Drug Hunter: From Vet School to Big Pharma | Martin Brenner Rerelease (1/3)

“Major pharma employer where Martin held drug discovery leadership roles”

AI-driven drug discovery platformsImmunotherapy development for difficult-to-treat cancersLeadership development in pharma and biotech

View Analysis

PBD Podcast · May 5, 2026

Gov. Wes Moore: Trans Kids, Newsom's Failures & 2028 Dark Horse | PBD #791

“Announced largest private investment in Maryland in over a decade, supporting 2,600 jobs”

Crime reduction and public safety strategy in BaltimoreEconomic diversification and business recruitment in blue statesLGBTQ+ policy: transgender sports, puberty blockers, parental involvement

View Analysis

Pharma and BioTech Daily · Apr 30, 2026

AstraZeneca's £300M UK Investment Resumes Amid FDA Pilot | Pharma and Biotech Daily

“Participating in FDA's real-time clinical trial review pilot; renewed £300M UK investment commitment despite prior drug pricing disputes”

FDA Real-Time Clinical Trial Review PilotAstraZeneca UK Investment and Drug PricingOncology Market Consolidation Strategy

View Analysis

Pharma and BioTech Daily · Apr 29, 2026

AstraZeneca's Breztri Asthma Approval Boosts $80B Goal | Pharma and Biotech Daily

“Breztri Aerosphere gained FDA approval for asthma, supporting company's $80 billion revenue goal by 2030”

FDA Drug Approval and RescissionData Integrity in Drug DevelopmentAI-Designed Therapeutics

View Analysis

Latent Space: The AI Engineer Podcast · Mar 24, 2026

🔬Why There Is No "AlphaFold for Materials" — AI for Materials Discovery with Heather Kulik

“Employs John Paul Genet as assistant director running their inverse design program in Sweden”

AI for Materials DiscoveryActive Learning in ChemistryMetal Organic Frameworks

View Analysis

Animal Spirits Podcast · Feb 23, 2026

Talk Your Book: Investing in Next Gen Tech Stocks

“Dropped out of QQQ in recent reconstitution; example of index changes”

NASDAQ Next Gen 100 ETF (QQQJ) positioning and performanceMarket concentration risk in mega-cap tech stocksEqual-weight versus market-cap weighting strategies

View Analysis

Congressional Dish · Jan 31, 2026

CD331: December 2025 — Authorizing Future Disasters

“Produced contaminated vaccine doses from Emergent BioSolutions contract overseen by Robert Kadlec”

Aviation Safety Regulation and Mid-Air Collision PreventionNational Defense Authorization Act (NDAA) Provisions and LoopholesEnvironmental Deregulation and Federal Land Protection

View Analysis

Leaked · Jan 27, 2026

Redfield on Risk: Gain-of-Function, Bird Flu, and the Next Pandemic

“COVID vaccine developer; vaccine withdrawn from market due to blood clot side effects”

COVID-19 Lab Origin Theory and Wuhan Institute of VirologyGain-of-Function Research Regulation and EnforcementmRNA Vaccine Safety and Adverse Events

View Analysis